Skip to main content
Group B streptococcal (GBS) disease is the leading cause of early-onset neonatal sepsis (within the first week of life) in the United States. Since the initial recommendations for perinatal prophylaxis in the 1990s, the incidence of GBS has declined by 80%.

Abstract & Commentary: New CDC guidelines to prevent neonatal strep

Group B streptococcal (GBS) disease is the leading cause of early-onset neonatal sepsis (within the first week of life) in the United States. Since the initial recommendations for perinatal prophylaxis in the 1990s, the incidence of GBS has declined by 80%.